The rise of vaporizing devices has created a new method for delivering cannabinoids, sparking significant discussion about their advantages and disadvantages, particularly regarding user health and safety. While vaporization may offer benefits over traditional smoking, such as reduced exposure to combustion byproducts, vaping cannabinoids is associated with notable risks. These risks primarily involve toxicity mechanisms and highlight the need for improved and regulated formulations.
Potential Advantages of Vaporization
A central argument for vaporizing cannabinoids is the potential for harm reduction when compared to traditional smoking methods. The combustion of cannabis during smoking generates a complex mixture of numerous toxic substances and carcinogens. Conversely, vaporization, which typically occurs at lower temperatures (cannabinoids vaporize around 284°F and combust at 446°F), is presumed to produce fewer of these harmful compounds, theoretically yielding a "cleaner" inhaled product (Giroud et al., 2015; Pearson, 2021a).
The capacity for discrete use, often with deodorized cannabis extracts that produce minimal odor, also contributes to its appeal by reducing social disturbance and the probability of detection (Giroud et al., 2015). In medical applications, vaping is frequently regarded as more suitable than smoking due to the potential for more precise dosing and a reduced intake of combustion-derived toxins (Giroud et al., 2015).
Compared to oral administration, inhalation (via smoking or vaping) offers significant pharmacokinetic advantages. Cannabinoids are rapidly absorbed into the bloodstream through the lungs, with peak plasma concentrations of THC and CBD typically reached within 3-10 minutes (Pearson, 2021a). This rapid absorption results in a quicker onset of effects and bypasses the extensive first-pass metabolism in the liver, a process that significantly reduces bioavailability and delays the effects of orally ingested cannabinoids. (Pearson, 2021b; Pearson, 2021a). Consequently, maximum cannabinoid concentrations are generally higher with inhalation than with oral routes, and bioavailability, while variable (ranging from 10-35% depending on inhalation characteristics), is also enhanced (Pearson, 2021a). This makes inhalation a preferred route for acute symptom relief in medical contexts.
Toxicity Mechanisms and Associated Risks
Despite perceived advantages, vaping cannabinoids carries substantial risks, as the vaporization process itself can introduce harmful compounds. The rise in electronic cigarette and vaping-related lung injuries (EVALI) that began in 2019 has led to thousands of hospitalizations and numerous fatalities, underscoring these dangers. (Pearson, 2021b). Research has begun to identify the various mechanisms of toxicity.
Contaminants can originate from extraction processes, potentially leaving residual solvents, or from the device hardware itself (NCIA, 2020; Pearson, 2021b). Device heating elements can leach heavy metals like nickel and lead into the aerosol, particularly at higher voltages (Olmedo et al., 2018; Pearson, 2021b). Common "cutting" agents such as propylene glycol (PG) and vegetable glycerin (VG) can also thermally degrade at high temperatures, producing toxic aldehydes (NCIA, 2020; Pearson, 2021b; Pearson, 2021a).
Vitamin E acetate (VEA), commonly used as a thickener in illicit THC vape products, has been strongly linked to EVALI (NCIA, 2020; Pearson, 2021b). While not harmful when ingested, its inhalation safety has not been established; it is thought to disrupt lung surfactant, potentially causing lung cell death and inflammation (NCIA, 2020; Pearson, 2021b). Microscopic studies of lung tissue from EVALI patients often indicate that the lung damage resembles a chemical burn affecting the airways, termed chemical pneumonitis, rather than a condition caused by oils accumulating in the lungs, which is a classic form of lipid pneumonia. This distinction is significant as it suggests direct harm to lung tissue from inhaled toxic substances, leading to patterns of acute lung injury (Butt et al., 2019; Pearson, 2021b). The illicit market greatly magnifies these risks due to unregulated products that often contain harmful additives and contaminants (NCIA, 2020).
The Path to Safer Vaping: Improved Formulations and Regulation
Addressing vaping toxicity requires a strategy focused on improved formulations, rigorous regulation, and consumer education. Ensuring vape liquid safety begins with using high-quality, pharmaceutical-grade ingredients with proven inhalation safety records (NCIA, 2020). For instance, formulations like live rosin, which utilize solventless extraction techniques, aim to provide purity and a full-spectrum cannabinoid and terpene profile, thereby avoiding concerns about residual solvents often associated with other extraction methods (Live Resin vs Rosin, n.d.; Lazarjani et al., 2021). Regardless of the extraction method, it is imperative that all ingredients meet established standards, such as those defined by the Food Chemicals Codex (FCC) or U.S. Pharmacopeia (USP), and that any extraction solvents, if used, are meticulously removed to permissible levels (NCIA, 2020; Pearson, 2021b).
Avoiding harmful additives is also crucial. Given its strong association with EVALI, VEA should not be incorporated into any inhalable product (NCIA, 2020). The inhalation safety of many artificial flavorings and high terpene concentrations remains unconfirmed, and some may degrade into harmful compounds upon heating or cause irritation (NCIA, 2020). Proactive state-level bans on certain additives, such as those implemented in Colorado, represent important steps in mitigating these risks (NCIA, 2020; Pearson, 2021b).
Beyond the formulation itself, safer device design and comprehensive emissions testing are paramount. Vaporizer hardware must be mechanically and electrically sound to prevent issues such as battery explosions or the leaching of heavy metals from coils. Furthermore, materials that come into contact with the cannabis formulation should be inert to avoid unwanted chemical reactions or leaching (NCIA, 2020). Standardized emissions testing, conducted under real-world usage conditions, is essential for identifying and quantifying any harmful degradants or contaminants produced during the vaporization process (NCIA, 2020).
Finally, robust regulation and consumer education form the cornerstone of a safer vaping landscape. The current lack of federal mandates for ingredient safety and testing protocols for inhalable cannabis products represents a significant regulatory deficiency (NCIA, 2020; Pearson, 2021b). Comprehensive regulations at both the state and potentially federal levels are needed to ensure product safety through mandated testing, accurate and transparent labeling, and stringent quality control measures throughout the supply chain. Efforts to displace the illicit market through sensible regulation and fair taxation are also vital for consumer protection (NCIA, 2020). Concurrently, consumers must be educated about the potential risks, how to identify safer products, and the importance of purchasing only from licensed, regulated sources (Pearson, 2021b).
Conclusion
The vaporization of cannabinoids presents a complex situation where perceived safety and ease of use are often overshadowed by a concerning lack of consumer awareness regarding significant, yet often mitigatable, risks. While it may offer a less detrimental alternative to smoking for some individuals (Giroud et al., 2015), the documented toxicity mechanisms, especially those brought to light by the emergence of EVALI (Butt et al., 2019; Pearson, 2021b), highlight the dangers associated with current practices, particularly within the unregulated market (NCIA, 2020). The way forward necessitates rigorous scientific investigation, the development of markedly improved and safer formulations, stringent quality control measures, comprehensive regulation of both products and devices, and robust consumer education programs. Only through such concerted efforts can the potential of vaporized cannabinoid delivery be explored responsibly, thereby minimizing risks and better understanding its potential benefits. The primary focus must remain on ensuring that any product intended for inhalation adheres to high safety standards to safeguard public health.
References
Arnovick, T. J. (2023, December 11). How to Make Live Rosin Cartridges. The Original Resinator. https://www.theoriginalresinator.com/blog/how-to-make-live-rosin-cartridges/
Butt, Y. M., Smith, M. L., Tazelaar, H. D., Vaszar, L. T., Swanson, K. L., Cecchini, M. J., Boland, J. M., Bois, M. C., Boyum, J. H., Froemming, A. T., Khoor, A., Mira-Avendano, I., Patel, A., & Larsen, B. T. (2019). Pathology of vaping-associated lung injury. The New England Journal of Medicine, 381(18), 1780-1781. https://doi.org/10.1056/NEJMc1913069
Farsalinos, K. E., & Rodu, B. (2018). Metal emissions from e-cigarettes: A risk assessment analysis of a recently-published study. Inhalation Toxicology, 30(7-8), 321-326. https://doi.org/10.1080/08958378.2018.1523262
Giroud, C., de Cesare, M., Berthet, A., Varlet, V., Concha-Lozano, N., & Favrat, B. (2015). E-cigarettes: A review of new trends in cannabis use. International Journal of Environmental Research and Public Health, 12(8), 9988-10008. https://doi.org/10.3390/ijerph120809988
Lazarjani, M. P., Young, O., Kebede, L., & Seyfoddin, A. (2021). Processing and extraction methods of medicinal cannabis: A narrative review. Journal of Cannabis Research, 3(1), 32. https://doi.org/10.1186/s42238-021-00087-9
Live Resin vs Rosin | Sunnyside Medical and Recreational Cannabis Dispensaries. (n.d.). Retrieved May 15, 2025, from https://www.sunnyside.shop/learn/live-resin-vs-rosin
National Cannabis Industry Association. (2020, January). The key to consumer safety: Displacing the illicit cannabis market recommendations for safe vaping. NCIA Policy Council. https://thecannabisindustry.org/wp-content/uploads/2020/01/NCIA-Safe-Vaping-WP_Jan27_v3.pdf
Olmedo, P., Goessler, W., Tanda, S., Grau-Perez, M., Jarmul, S., Aherrera, A., Chen, R., Hilpert, M., Cohen, J. E., Navas-Acien, A., & Rule, A. M. (2018). Metal concentrations in e-cigarette liquid and aerosol samples: The contribution of metallic coils. Environmental Health Perspectives, 126(2), 027010. https://doi.org/10.1289/EHP2175
Pearson, R. M. (2021a). MCST 603 Module 4 Lectures. University of Maryland School of Pharmacy.
Pearson, R. M. (2021b). MCST 603 Module 8 Lectures. University of Maryland School of Pharmacy.